Comanche Biopharma

Concord, MA · Founded 2020 · Privately Held (backing)

Operator of a biopharmaceutical company intended to develop an investigational siRNA medicine for preterm preeclampsia. Comanche Biopharma is based in Concord, MA and was founded in 2020. It was valued at $210 million at its later-stage round in Oct 2025, the last priced event on record. It has raised $136 million across 2 recorded rounds; the latest was a $37.5 million early-stage round in Dec 2023.

PMV mark · valuation
$210.0M
Oct 2026
Priced at
its later-stage round
Oct 2025
Total raised
$136.1M
Last round
Early Stage VC
Dec 2023

Who backs Comanche Biopharma?

8 investors
InvestorType
GVVenture capital
New Enterprise AssociatesVenture capital
F-Prime CapitalVenture capital
Atlas VentureOther
Broadview Ventures—
LAV (Lilly Asia Fund)—
Longview Healthcare Ventures—
Population Health Partners—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Comanche Biopharma investors

8 investors are on record for Comanche Biopharma, including GV, New Enterprise Associates, F-Prime Capital and Atlas Venture. The early-stage round in Dec 2023 drew 7 investors.

Free account
More of Comanche Biopharma with a free account
  • ·Watch Comanche Biopharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 8 firms already write checks for companies like Comanche Biopharma. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View